Anthill Ventures, an India-based venture capital firm and speed-scaling ecosystem, has on Thursday announced the launch of a new cohort for its Lumos Health program, which is designed for startups with disruptive solutions and health technologies.

Anthill said in a statement that the program focuses on high-impact verticals such as oncology, fertility, maternal health, genomics, cutting edge diagnostic, digital health and longevity.

According to the statement, the program will provide startups with access to Anthill’s global network of investors, mentors, and industry experts, as well as a range of resources designed to help startups grow their businesses.

The program has also established new partnerships with the Mazumdar Shaw Medical Foundation (MSMF), Kauvery Hospitals, DERBI Foundation and Makers Nest, providing startups with access to a total of 51 hospitals across the country through partners.

Startups will be provided with enhanced opportunities, including access to state-of-the-art wet lab facilities, invaluable clinical validation support, and comprehensive evaluation of their market-ready solutions.

The program is also supported by partner HealthCare Global (HCG), an Indian cancer care provider.

The program will also support startups on regulatory processes, funding advice and market access.

Each selected startup will be matched with “speedscalers”. The clinical speedscalers will help startups through clinical validation and regulatory support.

It is noted that business speedscalers will help startups strengthen their business model, GTM (Go-To-Market) strategy, and access to the market.

Startups will also get access to the larger network and up to $1 million worth of infrastructure support.

“As a global venture capital ecosystem, we recognize the immense potential of innovative startups to drive meaningful change and solve real-world problems,

“With the launch of the new cohort for our Lumos Health program, we are committed to providing startups with the resources and expertise they need to succeed, and we look forward to supporting the next generation of entrepreneurs and disruptors,” said Prasad Vanga, Founder and Managing Partner of Anthill Ventures.

MSMF Managing Director Paul Salins said the program allows the startups to accelerate their growths.

“Lumos Health’s comprehensive support and strategic guidance have proven instrumental in scaling startups to new heights,” he said.

The previous cohort run by Lumos Health performed excellently, with KroniKare raising their Series A round of funding and working with the government of Singapore to deploy an altered use case of their solution for COVID monitoring.

Lumos Health has evaluated over 500 startups and 11 startups successfully qualified for their scaling programs.

The program invites startups with breakthrough solutions, technology, and innovation for the healthcare industry, an established product market fit with customers, and a clear growth strategy.

Anthill is a global venture capital and speed scaling ecosystem that invests in bold entrepreneurs who are building the companies of tomorrow.

With a focus on healthcare, mediatech, urbantech and consumer lifestyle, Anthill provides targeted and timely interventions that drive transformational growth for early-stage startups.

Its unique approach helps companies #scalewithspeed, allowing them to reach stronger growth trajectories and unlock their full potential.

Anjali Ajaikumar is the co-founder of Lumos Health. She is an Executive Director on the Board of Health Care Group (HCG). She also oversees the business at Milann, a chain of fertility clinics.

She has an MBA in Entrepreneurship from Babson College, United States and extensive experience in healthcare.

India’s Good Health Clinic raises $10M Series A funding led by Left Lane Capital